Is the bioresorbable scaffold a sealing device?

Atherosclerosis

Volumn 221, Issue 1, 2012, Pages 36-37

  Gonzalo, Nieves ^a   Escaned, Javier ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Bioresorbable scaffolds; Vulnerable plaque

Indexed keywords

DARAPLADIB; PLACEBO;

ACUTE CORONARY SYNDROME; ATHEROSCLEROTIC PLAQUE; BARE METAL STENT; BIORESORBABLE SCAFFOLD; BIOSORPTION; CELL PROLIFERATION; EXTRACELLULAR MATRIX; FOLLOW UP; HEALING; HUMAN; IMPLANT; IN VIVO STUDY; INTRAVASCULAR ULTRASOUND; NEOINTIMA; NOTE; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RADIOFREQUENCY; SMOOTH MUSCLE FIBER; THIN CAP FIBROATHEROMA;

ABSORBABLE IMPLANTS; CORONARY ARTERY DISEASE; CORONARY VESSELS; ENDOVASCULAR PROCEDURES; HUMANS; NEOINTIMA; TISSUE SCAFFOLDS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84857034956     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.12.023     Document Type: Note

References (12)

1. Virmani R., Burke A.P., Farb A., Kolodgie F.D. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006, 47:C13-C18.
2. Meier B.R.S. Plaque sealing by coronary angioplasty. Cathet Cardiovasc Diagn 1995, 36:295-297.
3. Stone G.W., Maehara A., Lansky A.J., de Bruyne B., Cristea E., Mintz G.S., et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011, 364:226-235.
4. Brugaletta S., Radu M., Garcia-Garcia H.M., Heo J.H., Farooq V., Girasis C., et al. Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque?. Atherosclerosis 2012, 221:106-112.
5. Serruys P.W., Ormiston J.A., Onuma Y., Regar E., Gonzalo N., Garcia-Garcia H.M., et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 2009, 373:897-910.
6. Kubo T., Imanishi T., Kitabata H., Kuroi A., Ueno S., Yamano T., et al. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study. JACC Cardiovasc Imaging 2008, 1:475-484.
7. Nakazawa G., Finn A.V., Joner M., Ladich E., Kutys R., Mont E.K., et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 2008, 118:1138-1145.
8. Gonzalo N., Barlis P., Serruys P.W., Garcia-Garcia H.M., Onuma Y., Ligthart J., et al. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography. JACC Cardiovasc Intervent 2009, 2:445-452.
9. Nakazawa G., Otsuka F., Nakano M., Vorpahl M., Yazdani S.K., Ladich E., et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 2011, 57:1314-1322.
10. Nadkarni S.K., Pierce M.C., Park B.H., de Boer J.F., Whittaker P., Bouma B.E., et al. Measurement of collagen and smooth muscle cell content in atherosclerotic plaques using polarization-sensitive optical coherence tomography. J Am Coll Cardiol 2007, 49:1474-1481.
11. Takarada S., Imanishi T., Kubo T., Tanimoto T., Kitabata H., Nakamura N., et al. Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study. Atherosclerosis 2009, 202:491-497.
12. Serruys P.W., Garcia-Garcia H.M., Buszman P., Erne P., Verheye S., Ashermann M., et al. Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation 2008, 9:1172-1182.